Aromatase Inhibitor

An aromatase inhibitor is a medication used to treat certain kinds of breast cancer, the ones whose cells rely on the hormone estrogen to grow. Its name describes how it works: aromatase is an enzyme your body uses to produce estrogen, and an inhibitor is something that holds that process back. By reducing the amount of estrogen available, the medicine removes the fuel that hormone-sensitive cancer cells need.

These medicines are used mainly in women who have gone through menopause. After menopause, the ovaries largely stop making estrogen, and most of what remains comes from aromatase working in other tissues like fat and muscle. Blocking that enzyme can lower estrogen levels substantially. This is why aromatase inhibitors are typically chosen for postmenopausal women, while a medicine like Tamoxifen, which blocks estrogen's effect on cells in a different way, may be used across a broader range of situations.

Aromatase inhibitors are often part of adjuvant therapy, taken for several years after initial treatment to lower the chance that a hormone-receptor-positive cancer will return. Like any treatment, they come with possible side effects, including joint aches and effects on bone strength, which is why bone health is often watched alongside their use. Whether this kind of medicine fits depends on the specific biology of the cancer and your own health picture.

For the many women whose breast cancer is hormone-receptor-positive, treatments that target estrogen are among the most effective tools available. Aromatase inhibitors have become a cornerstone of long-term care for postmenopausal women, meaningfully reducing the risk of recurrence by addressing the very hormone that drove the cancer in the first place.

Understanding how these medicines work can make a years-long course of treatment feel more purposeful and less abstract. It also helps explain why your care team might pay close attention to your bones and joints during treatment, and why the conversation about hormone-blocking therapy is so closely tied to whether a cancer is estrogen-sensitive and whether you have reached menopause.